Influence of willow bark extract on cyclooxygenase activity and on tumor necrosis factor alpha or interleukin 1 beta release in vitro and ex vivo.
Wagner
Irmela
I
Greim
Cornelia
C
Laufer
Stefan
S
Heide
Lutz
L
Gleiter
Christoph H
CH
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D001592:Benzyl Alcohols / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D004305:Dose-Response Relationship, Drug; D005960:Glucosides; D006801:Humans; D020128:Inhibitory Concentration 50; D007375:Interleukin-1 / Q000378:metabolism; D007527:Isoenzymes / Q000187:drug effects; D008565:Membrane Proteins; D008517:Phytotherapy; D024301:Plant Bark; D010936:Plant Extracts / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D011451:Prostaglandin-Endoperoxide Synthases / Q000187:drug effects; D012016:Reference Values; D012216:Rheumatic Diseases / Q000188:drug therapy; D032108:Salix; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D001592:Benzyl Alcohols; D005960:Glucosides; D007375:Interleukin-1; D007527:Isoenzymes; D008565:Membrane Proteins; D010936:Plant Extracts; D014409:Tumor Necrosis Factor-alpha; C005696:salicin; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496511:PTGS1 protein, human; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases